BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8640966)

  • 1. New insights into the cardiac natriuretic peptides.
    Bonow RO
    Circulation; 1996 Jun; 93(11):1946-50. PubMed ID: 8640966
    [No Abstract]   [Full Text] [Related]  

  • 2. The natriuretic peptides in heart failure.
    Nicholls MG
    J Intern Med; 1994 Jun; 235(6):515-26. PubMed ID: 8207359
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of natriuretic peptides in pulmonary circulatory diseases].
    Hasegawa S; Uchida Y
    Nihon Naika Gakkai Zasshi; 1993 Jun; 82(6):863-6. PubMed ID: 8103072
    [No Abstract]   [Full Text] [Related]  

  • 5. [Natriuretic hormones in the diagnostics of heart failure].
    Laine M; Nieminen MS; Tikkanen I
    Duodecim; 1998; 114(19):1973-80. PubMed ID: 11717753
    [No Abstract]   [Full Text] [Related]  

  • 6. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
    Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS
    Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma natriuretic peptides as indicators of left ventricular remodeling after myocardial infarction.
    Yoshitomi Y; Nishikimi T; Kojima S; Kuramochi M; Takishita S; Kangawa K; Matsuo H
    Int J Cardiol; 1998 Apr; 64(2):153-60. PubMed ID: 9688434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuretic peptides in detection of heart failure.
    Dickstein K
    Lancet; 1998 Jan; 351(9095):4. PubMed ID: 9433417
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction.
    Arakawa N; Nakamura M; Aoki H; Hiramori K
    J Am Coll Cardiol; 1996 Jun; 27(7):1656-61. PubMed ID: 8636550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The examination of clinical prognostic importance of atrial and brain natriuretic peptide in patients with acute myocardial infarction].
    Mazurek W; Salomon P
    Pol Merkur Lekarski; 2002 Jan; 12(67):15-9. PubMed ID: 11957795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atrial natriuretic peptide for therapy of heart failure].
    Takeda N
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):270-5. PubMed ID: 15768591
    [No Abstract]   [Full Text] [Related]  

  • 12. The natriuretic peptides. Clinical applications in patients with COPD.
    Klinger JR; Cutaia M
    Chest; 1996 Nov; 110(5):1136-8. PubMed ID: 8915207
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.
    Campbell DJ; Mitchelhill KI; Schlicht SM; Booth RJ
    J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW
    Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton C; Turner J; Crozier IG; Yandle TG
    Circulation; 2003 Jun; 107(22):2786-92. PubMed ID: 12771003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemistry of natriuretic peptides.
    Yandle TG
    J Intern Med; 1994 Jun; 235(6):561-76. PubMed ID: 8207362
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
    Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
    Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ovine model of acute myocardial infarction and chronic left ventricular dysfunction.
    Ikram H; Rogers SJ; Charles CJ; Sands J; Richards AM; Bridgman PG; Gooneratne R
    Angiology; 1997 Aug; 48(8):679-88. PubMed ID: 9269137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic peptides.
    Levin ER; Gardner DG; Samson WK
    N Engl J Med; 1998 Jul; 339(5):321-8. PubMed ID: 9682046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.